Business Wire

bluebird bio Reports Third Quarter 2022 Financial Results and Highlights Operational Progress

SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today reported financial results and business highlights for the third quarter ended September ...
Business Wire

Bio-Rad Reports Second-Quarter 2022 Financial Results

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced financial results for the ...
Forbes

Should You Buy Bio-Rad Laboratories Stock After Its 50% Fall This Year?

Bio-Rad Laboratories stock (NYSE: BIO), a life science research and clinical diagnostic products company, has seen a 48% fall this year, significantly underperforming the broader S&P500 index, down 24 ...
MedCity News

Code Bio corrals $75M to skip viruses, use synthetic DNA for genetic meds delivery

Engineered viruses are the delivery vehicle of choice for many genetic medicines, but they pose several problems. In addition to the risk of dangerous immune responses, these viruses don’t go to all ...
Business Insider

A biotech trying to bring back the woolly mammoth just launched its first spinout company. See the 15-slide pitch deck Form Bio used to raise $30 million.

Colossal Bio, a biotech trying to resurrect the woolly mammoth, just spun out its first company. The new company, Form Bio, sells manufacturing software to life sciences companies. Insider got the ...
Nasdaq

bluebird bio Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Operational Progress

SOMERVILLE, Mass.--(BUSINESS WIRE)-- bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today reported financial results and business highlights for the fourth quarter and full year ...